BTIG Research Issues Positive Forecast for Merit Medical Systems (NASDAQ:MMSI) Stock Price

Key Points

• BTIG Research raised Merit Medical Systems’ price target from $105 to $110 and maintained a “buy” rating, implying 17.79% potential upside. The analyst consensus remains “Moderate Buy,” with an average target of $103.36.
• Merit Medical exceeded third-quarter expectations, reporting $416.24 million in revenue and $1.12 in EPS versus estimates of $410.56 million and $1.04, respectively. Revenue increased 8.4% year over year.
• The stock opened at $93.39 and is near its 52-week high of $94.85, while institutional investors own 99.66% of outstanding shares.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) had its price target hoisted by equities researchers at BTIG Research from $105.00 to $110.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a "buy" rating on the medical instruments supplier's stock. BTIG Research's price target would suggest a potential upside of 17.79% from the stock's current price.

Other equities analysts have also issued reports about the company. Freedom Capital began coverage on Merit Medical Systems in a research note on Tuesday. They set a "hold" rating for the company. Needham & Company LLC upped their price objective on Merit Medical Systems from $101.00 to $106.00 and gave the stock a "buy" rating in a report on Friday. JPMorgan Chase & Co. upped their price objective on Merit Medical Systems from $77.00 to $95.00 and gave the stock an "overweight" rating in a report on Friday, July 31st. Raymond James Financial reiterated an "outperform" rating and set a $100.00 target price on shares of Merit Medical Systems in a research report on Friday, July 31st. Finally, Weiss Ratings raised shares of Merit Medical Systems from a "hold (c)" rating to a "hold (c+)" rating in a report on Monday, October 12th. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $103.36.

Merit Medical Systems Stock Performance

MMSI opened at $93.39 on Friday. The stock has a market capitalization of $5.58 billion, a price-to-earnings ratio of 25.12, a PEG ratio of 2.30 and a beta of 0.51. The company has a fifty day moving average of $88.68 and a 200 day moving average of $77.12. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $94.85. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, topping the consensus estimate of $1.04 by $0.08. The business had revenue of $416.24 million for the quarter, compared to analysts' expectations of $410.56 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.92 EPS. As a group, sell-side analysts forecast that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Merit Medical Systems

Large investors have recently added to or reduced their stakes in the stock. Congress Asset Management Co. grew its stake in shares of Merit Medical Systems by 6.4% during the third quarter. Congress Asset Management Co. now owns 1,260,675 shares of the medical instruments supplier's stock valued at $108,708,000 after buying an additional 76,338 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Merit Medical Systems by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier's stock worth $85,287,000 after acquiring an additional 12,285 shares during the last quarter. William Blair Investment Management LLC bought a new stake in shares of Merit Medical Systems during the 2nd quarter worth approximately $78,894,000. Maverick Capital Ltd. boosted its holdings in Merit Medical Systems by 46.9% during the 1st quarter. Maverick Capital Ltd. now owns 714,081 shares of the medical instruments supplier's stock valued at $49,222,000 after acquiring an additional 227,915 shares during the period. Finally, Irenic Capital Management LP purchased a new position in Merit Medical Systems during the 2nd quarter valued at $37,623,000. 99.66% of the stock is owned by institutional investors.

Merit Medical Systems News Roundup

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q3 results exceeded expectations. Merit reported $416.2 million in revenue, up 8.4% year over year and above the $410.6 million consensus estimate. Non-GAAP EPS was $1.12 versus analysts’ $1.04 forecast, while GAAP EPS rose 51% to $0.70. Merit Medical Q3 2026 results
• Positive Sentiment: Growth and margins strengthened. Organic constant-currency revenue increased 9%, GAAP operating margin improved to 14.1% from 11.1%, and non-GAAP operating margin expanded to 21.3% from 19.7%. Year-to-date operating cash flow reached $175.2 million, supporting financial flexibility. Merit Medical profit report
• Positive Sentiment: Management raised full-year 2026 EPS guidance and narrowed its sales outlook, signaling confidence in earnings execution even as revenue expectations become more precise. Analysts responded by lifting price targets to $110 and $106. Analyst price-target revisions
• Positive Sentiment: Merit acquired Solo Pace, adding temporary pacing technology for transcatheter aortic valve replacement procedures and expanding its cardiac therapies platform. Solo Pace acquisition

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company's product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.